相关实验视频

Updated: May 12, 2025

Tracking Bispecific Antibody-Induced T Cell Trafficking Using Luciferase-Transduced Human T Cells

Tracking Bispecific Antibody-Induced T Cell Trafficking Using Luciferase-Transduced Human T Cells

Published on: May 12, 2023

多发性硬化症治疗的新前沿:从向共刺激分子到双特定抗体

Megan Reidy¹, Meerah Khan¹, Elizabeth A Mills²

¹Autoimmunity Center of Excellence, Multiple Sclerosis Center of Excellence, Arthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK 73104, USA.

International journal of molecular sciences

|May 7, 2025

概括

对多发性硬化症 (MS) 的新兴免疫疗法在向B细胞和其他免疫细胞以减少炎症和预防疾病进展方面表现有前途. 这些新型疗法可能为复发性复发性和渐进性MS提供更好的疗效和安全性.

科学领域:

神经免疫学神经免疫学
免疫治疗是一种免疫疗法.
多发性硬化症的发病因子

背景情况:

多发性硬化症 (MS) 是一种中枢神经系统自身免疫性疾病,目前已有20多种疾病修饰疗法 (DMT).
目前的DMT可以控制复发和炎症,但在很大程度上无法预防疾病的进展.
虽然在历史上被视为T细胞介导的,但有效的MS疗法越来越多地准B细胞.

研究的目的:

探索MS新型免疫疗法的生物学理由,优势,局限性和临床进展.
突出下一代针对B细胞,T细胞和先天性免疫组的治疗方法.
讨论这些疗法的潜力,以解决驱动多发性硬化症进展的外周和中央免疫反应.

主要方法:

对新兴免疫疗法的审查,包括抗CD40L抗体,CD19 CAR T细胞和BTK抑制剂.
对免疫激活和神经退行症的双重向的双特异性抗体的分析.
探索复发性复发性和渐进性MS的临床进展.

主要成果:

新型疗法显示出更强的向和消除中枢神经系统B细胞的能力.
这些方法影响T细胞和先天性免疫区,解决MS免疫病理学.
新兴的策略显示了减少炎症性脱髓化和疾病进展的潜力.

结论:

下一代多发性硬化症免疫疗法可能会显著减少炎症和疾病进展.
针对特定的免疫细胞种群提供了提高安全性概况的潜力,而免疫抑制的范围较小.
这些进展代表了在管理复发性复发性和渐进性MS形式的有希望的新前沿.

关键词:

BTKiKi 的意思是在CAR T细胞中.CD19 CD19 CD19 CD19 CD19 CD19 CD19 CD19 CD19 CD19 CD19 CD19 CD19 CD19 CD19 CD20 CD20 是一个CD20 CD20 是一个CD20.在CD40L中,CD40L是CD40L.这是DMT DMT.多发性硬化症多发性硬化症

更多相关视频

Two-photon Imaging of Cellular Dynamics in the Mouse Spinal Cord

Two-photon Imaging of Cellular Dynamics in the Mouse Spinal Cord

Published on: February 22, 2015

Imaging CD19+ B Cells in an Experimental Autoimmune Encephalomyelitis Mouse Model using Positron Emission Tomography

Imaging CD19+ B Cells in an Experimental Autoimmune Encephalomyelitis Mouse Model using Positron Emission Tomography

Published on: January 20, 2023

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Cell-surface Signaling

Cell-surface Signaling

Hormones—or any molecule that binds to a receptor, known as a ligand—that are lipid-insoluble (water-soluble) are not able to diffuse across the cell membrane. In order to be able to affect a cell without entering it, these hormones bind to receptors on the cell membrane. When a first messenger, a hormone, binds to a receptor, a signal cascade is set off, causing second messengers, proteins inside the cell, to become activated, resulting in downstream effects.